Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 246

1.

Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer.

Sahadevan K, Darby S, Leung HY, Mathers ME, Robson CN, Gnanapragasam VJ.

J Pathol. 2007 Sep;213(1):82-90.

PMID:
17607666
2.

The expression of fibroblast growth factors and their receptors in Hodgkin's lymphoma.

Khnykin D, Troen G, Berner JM, Delabie J.

J Pathol. 2006 Feb;208(3):431-8.

PMID:
16353171
3.
5.

Differential roles of fibroblast growth factor receptors (FGFR) 1, 2 and 3 in the regulation of S115 breast cancer cell growth.

Tarkkonen KM, Nilsson EM, Kähkönen TE, Dey JH, Heikkilä JE, Tuomela JM, Liu Q, Hynes NE, Härkönen PL.

PLoS One. 2012;7(11):e49970. doi: 10.1371/journal.pone.0049970. Epub 2012 Nov 21.

6.

Different abilities of the four FGFRs to mediate FGF-1 translocation are linked to differences in the receptor C-terminal tail.

Sørensen V, Wiedlocha A, Haugsten EM, Khnykin D, Wesche J, Olsnes S.

J Cell Sci. 2006 Oct 15;119(Pt 20):4332-41. Epub 2006 Sep 26.

7.
8.

Evidence for distinct alterations in the FGF axis in prostate cancer progression to an aggressive clinical phenotype.

Murphy T, Darby S, Mathers ME, Gnanapragasam VJ.

J Pathol. 2010 Mar;220(4):452-60. doi: 10.1002/path.2657.

PMID:
19960500
9.

Increased expression of FGF-8 isoforms and FGF receptors in human premalignant prostatic intraepithelial neoplasia lesions and prostate cancer.

Valve EM, Nevalainen MT, Nurmi MJ, Laato MK, Martikainen PM, Härkönen PL.

Lab Invest. 2001 Jun;81(6):815-26.

PMID:
11406643
10.

Alternative splicing of fibroblast growth factor receptors in human prostate cancer.

Kwabi-Addo B, Ropiquet F, Giri D, Ittmann M.

Prostate. 2001 Feb 1;46(2):163-72.

PMID:
11170144
11.

Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer.

Cole C, Lau S, Backen A, Clamp A, Rushton G, Dive C, Hodgkinson C, McVey R, Kitchener H, Jayson GC.

Cancer Biol Ther. 2010 Sep 1;10(5):495-504. Epub 2010 Sep 4.

12.

Differential regulation of fibroblast growth factor receptors in the regenerating amphibian spinal cord in vivo.

Zhang F, Clarke JD, Santos-Ruiz L, Ferretti P.

Neuroscience. 2002;114(4):837-48.

PMID:
12379240
13.

Amplification of FRS2 and activation of FGFR/FRS2 signaling pathway in high-grade liposarcoma.

Zhang K, Chu K, Wu X, Gao H, Wang J, Yuan YC, Loera S, Ho K, Wang Y, Chow W, Un F, Chu P, Yen Y.

Cancer Res. 2013 Feb 15;73(4):1298-307. doi: 10.1158/0008-5472.CAN-12-2086. Epub 2013 Feb 7.

14.

Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells.

Feng S, Wang F, Matsubara A, Kan M, McKeehan WL.

Cancer Res. 1997 Dec 1;57(23):5369-78.

15.

Fibroblast growth factor receptor 1 is principally responsible for fibroblast growth factor 2-induced catabolic activities in human articular chondrocytes.

Yan D, Chen D, Cool SM, van Wijnen AJ, Mikecz K, Murphy G, Im HJ.

Arthritis Res Ther. 2011 Aug 11;13(4):R130. doi: 10.1186/ar3441.

16.

Down-regulation of (IIIb) and (IIIc) isoforms of fibroblast growth factor receptor 2 (FGFR2) is associated with malignant progression in human prostate.

Naimi B, Latil A, Fournier G, Mangin P, Cussenot O, Berthon P.

Prostate. 2002 Aug 1;52(3):245-52.

PMID:
12111699
17.

Fibroblast growth factor receptor 4 regulates tumor invasion by coupling fibroblast growth factor signaling to extracellular matrix degradation.

Sugiyama N, Varjosalo M, Meller P, Lohi J, Hyytiäinen M, Kilpinen S, Kallioniemi O, Ingvarsen S, Engelholm LH, Taipale J, Alitalo K, Keski-Oja J, Lehti K.

Cancer Res. 2010 Oct 15;70(20):7851-61. doi: 10.1158/0008-5472.CAN-10-1223. Epub 2010 Sep 28.

18.

Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype.

Li H, Martin A, David V, Quarles LD.

Am J Physiol Endocrinol Metab. 2011 Mar;300(3):E508-17. doi: 10.1152/ajpendo.00499.2010. Epub 2010 Dec 7.

19.

Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4.

Hart KC, Robertson SC, Kanemitsu MY, Meyer AN, Tynan JA, Donoghue DJ.

Oncogene. 2000 Jul 6;19(29):3309-20.

20.

The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression.

Wang J, Stockton DW, Ittmann M.

Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6169-78.

Items per page

Supplemental Content

Write to the Help Desk